TrialRespiratory research2017

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.

Colin Reisner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.